Biodiagnostics in an era of global pandemics-From biosensing materials to data management

The novel corona virus SARS-CoV-2 (COVID-19) has exposed the world to challenges never before seen in fast diagnostics, monitoring, and prevention of the outbreak. As a result, different approaches for fast diagnostic and screening are made and yet to find the ideal way. The current mini-review provides and examines evidence-based innovative and rapid chemical sensing and related biodiagnostic solutions to deal with infectious disease and related pandemic emergencies, which could offer the best possible care for the general population and improve the approachability of the pandemic information, insights, and surrounding contexts. The review discusses how integration of sensing devices with big data analysis, artificial Intelligence or machine learning, and clinical decision support system, could improve the accuracy of the recorded patterns of the disease conditions within an ocean of information. At the end, the mini-review provides a prospective on the requirements to improve our coping of the pandemic-related biodiagnostics as well as future opportunities.

Automated summary

The article discusses the importance of rapid chemical sensing and bio-diagnostic solutions for COVID-19, emphasizing the integration of sensing devices with technologies such as big data analysis to improve the accuracy of disease records. It also provides an outlook on the future requirements and opportunities for enhancing pandemic-related bio-diagnostics.